Guo-Liang Yu has a plan for China.
Now with about 200 employees of his Epitomics Inc. in China — in biotech facilities built courtesy of district-level governments — and two burgeoning Chinese drug partnerships, Yu has become a sort of unofficial tour guide for a half-dozen biotech companies scouting space in the Middle Kingdom.
No comments:
Post a Comment